Page 1

NEVER SAY NEVER ROHTO November 11 , 2021 Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31 , 2022 ( Six Months Ended September 30 , 2021 ) Company name : ROHTO Pharmaceutical Co. , Ltd. Stock code : Representative : Contact : Telephone : 4527 Masashi Sugimoto , President and COO Masaya Saito , Vice President and Director 81- ( 0 ) 6-6758-8223 Scheduled date of filing of Quarterly Report : Scheduled date of dividend payment : Supplementary materials for quarterly financial results : Quarterly financial results meeting : [ Japanese GAAP ] Stock Exchange listing : TSE , First Section URL : https://www.rohto.co.jp/ November 12 , 2021 December 2 , 2021 Yes Yes ( for institutional investors and analysts ) ( All amounts are rounded down to the nearest million yen . ) 1. Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31 , 2022 ( April 1 , 2021 - September 30 , 2021 ) ( 1 ) Consolidated results of operations ( Percentages represent year - on - year changes . ) Six months ended Sep. 30 , 2022 Six months ended Sep. 30 , 2021 Note : Comprehensive income ( Millions of yen ) : Net sales Millions of yen 91,019 83,004 Operating income A8.2 % Millions of yen 13,771 10,173 Ordinary income % Millions of yen Profit attributable to owners of parent % Millions of yen % Δ2.1 13,514 10,484 - A3.7 10,756 5,797 A20.6 Six months ended Sep. 30 , 2022 : Six months ended Sep. 30 , 2021 : 13,306 ( - % ) 5,384 ( 13.0 % ) Basic net income per share Diluted net income per share Six months ended Sep. 30 , 2022 Yen 94.30 50.83 Yen 94.03 50.68 Six months ended Sep. 30 , 2021 Note 1 : Beginning with the first half of the fiscal year ending on March 31 , 2022 , the Company has applied Accounting Standard for Revenue Recognition ( ASBJ Statement No. 29 , March 31 , 2020 ) . All figures for the first half incorporate this accounting standard and comparisons with the first quarter of the previous fiscal year are omitted . Note 2 : The provisional accounting treatment for business combinations has been finalized at the end of the fiscal year ended March 31 , 2022. The figures for the first half of the fiscal year ended March 31 , 2021 have been restated accordingly . ( 2 ) Consolidated financial position Total assets Net assets Equity ratio Millions of yen Millions of yen As of Sep. 30 , 2022 As of Mar. 31 , 2021 261,458 225,790 172,567 156,612 Reference : Shareholders ' equity ( Millions of yen ) : As of Sep. 30 , 2022 : 166,101 % 63.5 68.9 As of Mar. 31 , 2021 : 155,525 2. Dividends Fiscal year ended Mar. 31 , 2021 Fiscal year ending Mar. 31 , 2022 Fiscal year ending Mar. 31 , 2022 ( forecast ) Dividend per share 1Q - end 2Q - end 3Q - end Year - end Total Yen Yen Yen 13.00 Yen 15.00 Yen 28.00 15.00 Note : Revisions to the most recently announced dividend forecast : None 15.00 30.00